CDKN2A and cutaneous melanoma: While pancreatic carcinoma and cutaneous melanoma are of highly divergent embryologic origin, both are most frequently associated with mutations inducing constitutive Ras pathway activation and both are associated with frequent loss of function mutations or epigenetic silencing of the p16 tumor suppressor.